Novozymes OneHealth cultivates global probiotic market to help develop industry of page 2 | investinchina.chinadaily.com.cn

Novozymes OneHealth cultivates global probiotic market to help develop industry

chinadaily.com.cn Updated: 2023-05-29
The booth of Novozymes OneHealth at the 2023 China Gut Conference in Beijing. [Photo provided to chinadaily.com.cn]

The main businesses of OneHealth are currently gastrointestinal health, brain health, immune health, metabolism and oral health. In the development of probiotic products, OneHealth has bacterial strain products including Lactobacillus reuteri DSM17648, Bifidobacterium longum 35624 and Bifidobacterium longum 1714.

< 1 2 3 4 5 6 >